Morphogenesis and release of fowlpox virus

Journal of General Virology

Volumn 81, Issue 3, 2000, Pages 675-687

  Boulanger, Denise ^a,b   Smith, T ^a,c   Skinner, M A ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CYTOCHALASIN D; GENE PRODUCT; GLUCOSAMINE; MONENSIN; MUTANT PROTEIN; VIRUS PROTEIN;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL MEMBRANE; ELECTRON MICROSCOPY; EMBRYO; FIBROBLAST; FOWLPOX VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS ENVELOPE; VIRUS MORPHOGENESIS; VIRUS PARTICLE;

ANIMALIA; DNA VIRUSES; FOWLPOX VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0033961288     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-3-675     Document Type: Article

References (54)

1. Arhelger, R. B. & Randall, C. C. (1964). Electron microscopic observations on the development of fowlpox virus in chorioallantoic membrane. Virology 22, 59-66.
2. Blasco, R. & Moss, B. (1991). Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. Journal of Virology 65, 5910-5920.
3. Blasco, R. & Moss, B. (1992). Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. Journal of Virology 66, 4170-4179.
4. Blasco, R., Sisler, J. R. & Moss, B. (1993). Dissociation of progeny vaccinia virus from the cell-membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. Journal of Virology 67, 3319-3325.
5. Bohn, W., Rutter, G., Hohenberg, H., Mannweiler, K. & Nobis, P. (1986). Involvement of actin filaments in budding of measles virus: studies on cytoskeletons of infected cells. Virology 149, 91-106.
6. Boulanger, D., Green, P., Smith, T., Czerny, C. P. & Skinner, M. A. (1998). The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic. Journal of Virology 72, 170-179.
7. Calvert, J. G., Ogawa, R., Yanagida, N. & Nazerian, K. (1992). Identification and functional analysis of the fowlpox virus homolog of the vaccinia virus p37K major envelope antigen gene. Virology 191, 783-792.
8. Cudmore, S., Cossart, P., Griffiths, G. & Way, M. (1995). Actin-based motility of vaccinia virus. Nature 378, 636-638.
9. Cudmore, S., Reckmann, I. & Way, M. (1997). Viral manipulations of the actin cytoskeleton. Trends in Microbiology 5, 142-148.
10. Dales, S. (1963). The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid. Journal of Cell Biology 18, 51-72.
11. Dales, S. & Mosbach, E. H. (1968). Vaccinia as a model for membrane biogenesis. Virology 35, 564-583.
12. Duncan, S. A. & Smith, G. L. (1992). Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. Journal of Virology 66, 1610-1621.
13. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
14. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
15. Hiller, G., Weber, K., Schneider, L., Parajsz, C. & Jungwirth, C. (1979). Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98, 142-153.
16. Hirt, P., Hiller, G. & Wittek, R. (1986). Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. Journal of Virology 58, 757-764.
17. Hollinshead, M., Vanderplasschen, A., Smith, G. L. & Vaux, D. J. (1999). Vaccinia virus intracellular mature virions contain only one lipid membrane. Journal of Virology 73, 1503-1517.
18. Ichihashi, Y., Matsumoto, S. & Dales, S. (1971). Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46, 507-532.
19. Isaacs, S. N., Wolffe, E. J., Payne, L. G. & Moss, B. (1992). Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. Journal of Virology 66, 7217-7224.
20. Kato, N., Eggers, H. J. & Rolly, H. (1969). Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyI-4-chlorobenzoyl-hydrazine. Journal of Experimental Medicine 129, 795-808.
21. Limbach, K. J. & Paoletti, E. (1996). Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiology and Infection 116, 241-256.
22. McIntosh, A. A. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. Journal of Virology 70, 272-281.
23. Maiti, N. K., Oberoi, M. S. & Sharma, S. N. (1991). Comparative-studies on the antigenicity of extracellular and intracellular viruses of fowlpox. Comparative Immunology Microbiology and Infectious Diseases 14, 59-62.
24. Meyer, R. K., Burger, M. M., Tschannen, R. & Schafer, R. (1981). Actin filament bundles in vaccinia virus infected fibroblasts. Archives of Virology 67, 11-18.
25. Morgan, C. (1976). Vaccinia virus reexamined: development and release. Virology 73, 43-58.
26. Murti, K. G. & Goorha, R. (1983). Interaction of frog virus-3 with the cytoskeleton. I. Altered organization of microtubules, intermediate filaments, and microfilaments. Journal of Cell Biology 96, 1248-1257.
27. Murti, K. G., Chen, M. & Goorha, R. (1985). Interaction of frog virus 3 with the cytomatrix. III. Role of microfilaments in virus release. Virology 142, 317-325.
28. Ogawa, R., Calvert, J. G., Yanagida, N. & Nazerian, K. (1993). Insertional inactivation of a fowlpox virus homolog of the vaccinia virus F12L gene inhibits the release of enveloped virions. Journal of General Virology 74, 55-64.
29. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
30. Payne, L. G. & Kristenson, K. (1979). Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. Journal of Virology 32, 614-622.
31. Payne, L. G. & Kristensson, K. (1982a). The effect of cytochalasin-D and monensin on enveloped vaccinia virus release. Archives of Virology 74, 11-20.
32. Payne, L. G. & Kristensson, K. (1982b). Effect of glycosylation inhibitors on the release of enveloped vaccinia virus. Journal of Virology 41, 367-375.
33. Pulford, D. J. & Britton, P. (1990). Expression and cellular localisation of porcine transmissible gastroenteritis virus N and M proteins by recombinant vaccinia viruses. Virus Research 18, 203-218.
34. Rodriguez, J. F. & Smith, G. L. (1990). Inducible gene-expression from vaccinia virus vectors. Virology 177, 239-250.
35. Roper, R. L., Payne, L. G. & Moss, B. (1996). Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. Journal of Virology 70, 3753-3762.
36. Roper, R. L., Wolffe, E. J., Weisberg, A. & Moss, B. (1998). The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. Journal of Virology 72, 4192-4204.
37. Rottger, S., Frischknecht, F., Reckmann, I., Smith, G. L. & Way, M. (1999). Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. Journal of Virology 73, 2863-2875.
38. Sanders, M. C. & Theriot, J. A. (1996). Tails from the hall of infection: actin-based motility of pathogens. Trends in Microbiology 4, 211-213.
39. Sanderson, C. M., Frischknecht, F., Way, M., Hollinshead, M. & Smith, G. L. (1998). Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. Journal of General Virology 79, 1415-1425.
40. Schmelz, M., Sodeik, B., Ericsson, M., Wolffe, E. J., Shida, H., Hiller, G. & Griffiths, G. (1994). Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. Journal of Virology 68, 130-147.
41. Schmutz, C., Payne, L. G., Gubser, J. & Wittek, R. (1991). A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release. Journal of Virology 65, 3435-3442.
42. Shida, H. (1986). Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
43. Smith, G. L., Chan, Y. S. & Howard, S. T. (1991). Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. Journal of General Virology 72, 1349-1376.
44. Sodeik, B., Doms, R. W., Ericsson, M., Hiller, G., Machamer, C. E., Vanthof, W., Vanmeer, G., Moss, B. & Griffiths, G. (1993). Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. Journal of Cell Biology 121, 521-541.
45. Stokes, G. V. (1976). High-voltage electron microscope study of the release of vaccinia virus from whole cells. Journal of Virology 18, 636-643.
46. Tooze, J., Hollinshead, M., Reis, B., Radsak, K. & Kern, H. (1993). Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. European Journal of Cell Biology 60, 163-178.
47. Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A. & Tsukita, S. (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. Journal of Cell Biology 126, 391-401.
48. Tsutsui, K. (1983). Release of vaccinia virus from FL cells infected with the IHD-W strain. Journal of Electron Microscopy 32, 125-140.
49. Tsutsui, K., Uno, F., Akatsuka, K. & Nii, S. (1983). Electron microscopic study on vaccinia virus release. Archives of Virology 75, 213-218.
50. Ulaeto, D., Grosenbach, D. & Hruby, D. E. (1995). Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor p37. Journal of General Virology 76, 103-111.
51. Weintraub, S., Stern, W. & Dales, S. (1977). Biogenesis of vaccinia. Effects of inhibitors of glycosylation on virus-mediated activities. Virology 78, 315-322.
52. Wolffe, E. J., Isaacs, S. N. & Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. Journal of Virology 67, 4732-4741.
53. Wolffe, E. J., Katz, E., Weisberg, A. & Moss, B. (1997). The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. Journal of Virology 71, 3904-3915.
54. Wolffe, E. J., Weisberg, A. S. & Moss, B. (1998). Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 244, 20-26.